$0.11 EPS Expected for The Marcus (MCS); Capital International Investors Lifted Its Abbott Laboratories (ABT) Stake

Analysts expect The Marcus Corporation (NYSE:MCS) to report $0.11 EPS on April, 25.They anticipate $0.24 EPS change or 68.57% from last quarter’s $0.35 EPS. MCS’s profit would be $3.39M giving it 91.27 P/E if the $0.11 EPS is correct. After having $0.41 EPS previously, The Marcus Corporation’s analysts see -73.